-
Navigating Hospital Discharge Decisions
Patients with advanced cancer often go to rehabilitation facilities after a hospital stay in hopes of gaining the strength for further treatment, but the majority do not go on to receive additional cancer therapy, a study reports.
by Ashley P. Taylor
-
Misunderstandings About Cancer DNA Tests
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
-
First Ladies of Africa Issue Call to Address Cancer Crisis
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
-
September 27: The Week in Cancer News
A study examines how poor and minority patients are more likely to be diagnosed with cancer in the emergency room, and a cancer survivor considers the lasting effects of chemotherapy.
by Bradley Jones
-
Forward Look
Measuring Treatment EffectivenessOutcomes are often evaluated using progression-free survival.
by Jasenka Piljac Zegarac
-
Forward Look
New Option for Treating Pain From Bone MetastasesStudy supports use of single-session, higher-dose radiation.
by Jane Langille
-
Finding More Targets for CAR-T Cells
CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
-
Forward Look
What’s Next? Fall 2019Researchers look for easier ways to screen for colorectal cancer in Nigeria.
by Bradley Jones
-
Q&A
The Promise of CRISPRBiochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.
by Marci A. Landsmann
-
September 13: The Week in Cancer News
Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.
by Kate Yandell
Cancer Talk
Treating Smoldering Multiple Myeloma
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona